483 Document: Ipsen BioPharm Ltd, Sep 12, 2017

FDANews 483 Ipsen BioPharm Ltd Sep 12 2017 top
Susan T. Hadman FDA Investigator Shawn E. Larson FDA Investigator

On Sep 12, 2017, the FDA inspected Ipsen BioPharm Ltd's Wrexham site. Explore the inspectional observations.